Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
For the University of California, San Francisco (UCSF) study, 10 people living with HIV took a mix of experimental ...
HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...
The treatment landscape for HIV is discussed by a panel led by Dr Welch. Adam C. Welch, PharmD, MBA: Let’s get into some of those treatments. Shauna, can you provide an overview of how we treat HIV?
Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.
Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.
IFLScience on MSN
7th Person Cured Of HIV After Stem Cell Donation Offers Hope Of Expanded Treatment Options
For the seventh time on record, a patient with both HIV and cancer has had the virus eliminated from their body. As in most ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
THERE IS CURRENTLY NO CURE TO AN HIV INFECTION. HOWEVER, RESEARCHERS AT JOHNS HOPKINS MEDICINE HAVE DISCOVERED AN ENZYME THAT PLAYS A KEY ROLE IN REPLICATING HIV. OUR MINDY BASARA HAS BEEN FOLLOWING ...
A new Correspondence Letter in The Lancet HIV from AIDS Healthcare Foundation (AHF) raises concerns that the World Health Organization’s recommended three-test system for HIV diagnosis—designed to ...
World AIDS Day came Monday, and it’s worth remembering the scale of loss before turning to the work still in front of us.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results